FHC
CRDF icon

First Heartland Consultants’s Cardiff Oncology CRDF Stock Holding History

First Heartland Consultants’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-317
Closed -$103 – 327
2016
Q2 		$103 Buy
+317
New +$109K 0.01% 293

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

First Heartland Consultants's CRDF Position: Q3 2016 in Review

First Heartland Consultants sold out of Cardiff Oncology (CRDF) in Q3 2016, closing a stake of 317 shares — an estimated $103 sold.

First Heartland Consultants first reported a position in CRDF in Q2 2016 and held it in 1 quarter. The position peaked at $103 in Q2 2016. 66 funds tracked by Wall St. Rank hold CRDF as of Q3 2016.

  • First Heartland Consultants reported no remaining Cardiff Oncology position as of Q3 2016 after selling out during the quarter.
  • First Heartland Consultants sold 317 Cardiff Oncology shares in Q3 2016, an estimated $103.
  • First Heartland Consultants first reported a position in Cardiff Oncology in Q2 2016 and held it in 1 quarter.
  • First Heartland Consultants's Cardiff Oncology position peaked at $103 in Q2 2016.
  • 66 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2016.

Based on First Heartland Consultants's 13F filing for Q3 2016, filed 23 Nov 2016.